Author

B. Harmon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:gene regulatory network inference· 3 Organism:human· 3 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. DeMichele· 2 shared C. Curtis· 2 shared F. Couch· 2 shared K. E. Houlahan· 2 shared K. Gallagher· 2 shared M. Kilgore· 2 shared S. H. Strand· 2 shared S. Wei· 2 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. DeMichele

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome.

S. H. Strand, K. E. Houlahan, V. Branch, T. Lynch, B. Harmon, F. Couch, K. Gallagher, M. Kilgore, S. Wei, A. DeMichele, T. King, P. McAuliffe, C. Curtis, K. Owzar, J. R. Marks, , R. B. West

The paper analyzes molecular differences in ductal carcinoma in situ (DCIS) by self-reported race and outcome groups, identifying variations in gene expression, tumor microenvironment, and copy number variations between Black and White women.

bioRxiv · Sep 28, 2023Cancer Biology

DCIS genomic signatures define biology and clinical outcome: Human Tumor Atlas Network (HTAN) analysis of TBCRC 038 and RAHBT cohorts

S. H. Strand, B. Rivero-Gutierrez, K. E. Houlahan, J. A. Seoane, L. M. King, T. Risom, L. A. Simpson, S. Vennam, A. Khan, L. Cisneros, T. Hardman, B. Harmon, F. Couch, K. Gallagher, M. Kilgore, , K Owzar

The paper develops a classifier for DCIS recurrence using genomic data from two cohorts and identifies pathways and stroma-specific signatures associated with progression to invasive cancer.

bioRxiv · Jun 16, 2021 · PreprintCancer Biology

Development of Potent and Effective Synthetic SARS-CoV-2 Neutralizing Nanobodies

M. A. Stefan, Y. K. Light, J. L. Schwedler, P. R. McIlroy, C. M. Courtney, E. A. Saada, C. E. Thatcher, A. M. Phillips, F. A. Bourguet, C. M. Mageeney, S. A. McCloy, N. M. Collette, O. A. Negrete, J. S. Schoeniger, D. R. Weilhammer, B. Harmon

This paper identifies and characterizes potent SARS-CoV-2 neutralizing nanobodies that block viral entry and show efficacy in vivo.

bioRxiv · May 6, 2021Immunology

Insertional oncogenesis by HPV70 revealed by multiple genomic analyses in a clinically HPV-negative cervical cancer

A. Van Arsdale, N. E. Patterson, E. C. Maggi, L. Agoni, K. Van Doorslaer, B. Harmon, N. Nevadunsky, D. Y. S. Kuo, M. H. Einstein, J. Lenz, C. Montagna

The paper identifies HPV70 insertion into BCL11B in an HPV-negative cervical cancer through genomic analyses, suggesting HPV70's oncogenic potential and novel BCL11B variants.

bioRxiv · May 10, 2019Cancer Biology